(Q52233138)

27 April 2018

title

Down-regulation of hepatic lipase gene expression and activity by fenofibrate (English)

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

13 November 2022

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

13 November 2022

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

13 November 2022

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

13 November 2022

1

1 reference

27 April 2018

Julia Peinado-Onsurbe

object named as

J Peinado-Onsurbe

2

0 references

Johan Auwerx

3

object named as

J Auwerx

1 reference

27 April 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1739751

13 November 2022

publication date

1 January 1992

1 reference

27 April 2018

24 January 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1739751

full work available at URL

13 November 2022

number of pages

4

1 reference

based on heuristic

inferred from page(s)

https://api.elsevier.com/content/article/PII:000527609290115C?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

https://api.elsevier.com/content/article/PII:000527609290115C?httpAccept=text/plain

13 November 2022

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Biochimica et Biophysica Acta

13 November 2022

published in

1 reference

27 April 2018

volume

1123

1 reference

27 April 2018

issue

2

1 reference

27 April 2018

page(s)

227-230

1 reference

27 April 2018

Effects of fibrates on serum lipids and atherosclerosis

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Fibric acids: effects on lipids and lipoprotein metabolism

13 November 2022

2

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia

13 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Potential use of fenofibrate and other fibric acid derivatives in the clinic

13 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia

13 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Effects of ciprofibrate and fenofibrate on liver lipids and lipoprotein synthesis in normo- and hyperlipidemic rats

13 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Alterations in rat serum lipids and apolipoproteins following clofibrate treatment

13 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

The immediate and long term effects of clofibrate on the metabolism of the perfused rat liver

13 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Modification of metabolism and distribution of lipids by ethyl chlorophenoxyisobutyrate

13 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

THE COMMON MODE OF ACTION OF THREE NEW CLASSES OF INHIBITORS OF CHOLESTEROL BIOSYNTHESIS

13 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Comparison of assay methods for selective measurement of plasma lipase. The effect of clofibrate on hepatic and lipoprotein lipase in normals and patients with hypertriglyceridemia

13 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Effect of clofibrate on postheparin plasma triglyceride lipase activities in patients with hypertriglyceridemia

13 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Increase in Lipoprotein Lipase during Clofibrate Treatment of Hypertriglyceridemia in Patients on Hemodialysis

13 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Effects of bezafibrate on the serum lipoprotein lipid and apolipoprotein composition, lipoprotein triglyceride removal capacity and the fatty acid composition of the plasma lipid esters

13 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

13 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Hepatic endothelial lipase antiserum influences rat plasma low and high density lipoproteins in vivo

13 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Large buoyant LDL-like particles in hepatic lipase deficiency.

13 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Accumulation of intermediate density lipoprotein in plasma after intravenous administration of hepatic triglyceride lipase antibody in rats

13 November 2022

21

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase

13 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

On the metabolic function of heparin-releasable liver lipase

13 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Effects of heparin infusion on plasma lipoproteins in subjects with lipoprotein lipase deficiency. Evidence for a role of hepatic endothelial lipase in the metabolism of high-density lipoprotein subfractions in man

13 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease

13 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Human hepatic triglyceride lipase: cDNA cloning, amino acid sequence and expression in a cultured cell line

13 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Isolation of a recombinant copy of the gene encoding C/EBP

13 November 2022

28

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Effect of starvation on lipoprotein lipase activity in the liver of developing rats

13 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Intralipid administration induces a lipoprotein lipase-like activity in the livers of starved adult rats

13 November 2022

31

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Lipoprotein lipase in liver. Release by heparin and immunocytochemical localization.

13 November 2022

32

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Lipoprotein-cholesterol distributions in selected North American populations: the lipid research clinics program prevalence study

13 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study

13 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

Alterations in Thyroid Status Modulate Apolipoprotein, Hepatic Triglyceride Lipase, and Low Density Lipoprotein Receptor in Rats*

13 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0005-2760(92)90115-C

13 November 2022

Identifiers

1 reference

27 April 2018

1 reference

27 April 2018